GEFTINAT 250MG
Prescription Required
Sale price
₹ 2,500.00
Regular price
MRP: ₹ 5,531.25
55% OFF
Inclusive of all taxes.
Couldn't load pickup availability
GEFTINAT 250MG
Regular price
₹ 2,500.00
Regular price
₹ 5,531.25
Sale price
₹ 2,500.00
(-55%)
Unit price
per
GEFTINAT 250MG
Sale price
₹ 2,500.00
Regular price
MRP: ₹ 5,531.25
55% OFF
- Introduction
- Uses
- Storage
- Safety
- Side effects
- Abouts RareMeds
- Disclaimer
Introduction
Geftinat 250mg Tablet contains gefitinib, an EGFR tyrosine-kinase inhibitor that helps control cancer cells with activating EGFR mutations.
Uses
Geftinat 250mg Tablet is used for the treatment of eligible patients with locally advanced or metastatic non-small cell lung cancer.
Storage
- Store below 30°C in a dry place.
- Protect from moisture, heat and sunlight.
Safety Information
- Treatment requires oncology supervision and appropriate biomarker testing.
- Monitor liver function.
- Report breathing problems, severe diarrhoea, severe rash or eye pain immediately.
Possible Side Effects
Possible side effects may include:
- Skin rash
- Diarrhoea
- Nausea
- Loss of appetite
- Fatigue
- Dry skin
- Mouth sores
- Elevated liver enzymes
About RareMeds
We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.
The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.
No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.
Disclaimer
Geftinat is a prescription anticancer medicine.
It should only be used under the supervision of a qualified oncologist.